communityacquir
pneumonia
cap
remain
major
caus
morbid
mortal
streptococcu
pneumonia
mycoplasma
pneumonia
influenza
viru
infa
respiratori
syncyti
viru
rsv
adenovirus
adv
recogn
import
caus
despit
effort
find
evid
bacteri
viral
pathogen
etiolog
agent
patient
cap
etiolog
remain
elus
reason
report
low
yield
use
antibiot
collect
sampl
sampl
type
test
diagnost
panel
use
patient
diagnost
method
use
rang
cultur
sputum
blood
throat
swab
antigen
test
eg
urinari
antigen
test
molecular
test
studi
question
valu
bacteri
sputum
cultur
furthermor
serolog
test
requir
convalescentphas
sampl
therefor
use
initi
phase
determin
etiolog
blood
cultur
provid
microbiolog
diagnosi
addit
urinari
antigen
detect
assay
pneumonia
legionella
pneumophila
improv
yield
past
year
pcr
develop
mani
viral
bacteri
pathogen
result
higher
diagnost
knowledg
probabl
etiolog
agent
may
inform
treatment
therebi
potenti
reduc
use
antibiot
eventu
antimicrobi
studi
aim
assess
ad
valu
viral
bacteri
molecular
diagnost
oropharyng
swab
op
comparison
sputum
sampl
diagnosi
cap
studi
embed
within
larger
prospect
observ
cohort
studi
perform
april
march
patient
cap
age
year
older
attend
emerg
ward
two
teach
hospit
tilburg
netherland
suspicion
cap
includ
cap
defin
presenc
new
progress
infiltr
chest
radiograph
clinic
symptom
suggest
lower
respiratori
tract
infect
exclus
criteria
recent
hospit
week
resid
longterm
care
facil
ii
known
bronchial
obstruct
histori
postobstruct
pneumonia
except
chronic
obstruct
pulmonari
diseas
iii
primari
lung
cancer
anoth
malign
metastat
lung
iv
aid
known
suspect
pneumocysti
jirovecii
pneumonia
v
known
suspect
activ
tuberculosi
case
report
form
obtain
patient
collect
data
age
gender
current
smoke
comorbid
clinic
symptom
prior
antimicrobi
treatment
admiss
blood
analysi
accord
protocol
emerg
ward
op
sputum
sampl
urin
sampl
serum
sampl
taken
two
set
blood
sampl
obtain
compar
evalu
patient
complet
sampl
set
avail
includ
blood
urin
specimen
process
immedi
sputum
sampl
divid
two
equal
aliquot
one
bacteri
cultur
anoth
store
realtim
revers
transcriptas
pcr
rt
qpcr
test
op
use
sampl
posterior
oropharyng
mucos
membran
use
commerci
rigid
cottontip
swab
mwe
wiltshir
uk
swab
op
specimen
place
ml
viru
transport
medium
gli
medium
store
perform
qpcr
assay
sputum
sampl
blood
sampl
cultur
accord
standard
microbiolog
procedur
sputum
sampl
examin
microscopi
sputum
sampl
presenc
polymorphonuclear
leukocyt
squamou
cell
per
field
consid
accept
cultur
signific
bacteri
growth
sputum
sampl
defin
growth
predomin
organ
cultur
plate
compat
result
gram
stain
urin
sampl
test
urinari
antigen
detect
test
pneumonia
l
pneumophila
pneumococc
urinari
antigen
test
legionella
urinari
antigen
test
aler
portland
usa
oropharyng
sputum
sampl
test
rt
qpcr
presenc
respiratori
virus
bacteria
includ
adv
human
bocaviru
hbov
ki
polyomavirus
wu
polyomavirus
kipyv
wupyv
human
metapneumoviru
hmpv
human
rhinoviru
hrv
human
coronavirus
hcov
parainfluenza
virus
piv
influenza
virus
b
infa
infb
rsv
l
pneumophila
pneumonia
chlamydophila
psittaci
chlamydophila
pneumonia
coxiella
burnetii
serum
sampl
test
presenc
c
burnetii
rt
qpcr
procedur
perform
rt
qpcr
result
express
cycl
thresholdvalu
consensu
standard
use
assess
sensit
op
sputum
sampl
posit
result
either
op
sputum
sampl
consid
gold
standard
presenc
pathogen
use
calcul
sensit
op
sputum
sampl
detect
respiratori
pathogen
mcnemar
test
use
assess
signific
differ
two
correl
proport
analys
conduct
use
pasw
statist
ibm
compani
chicago
vs
usa
patient
cap
evalu
studi
period
subset
met
inclus
criteria
complet
sampl
includ
studi
patient
rang
age
year
mean
year
patient
male
thirtytwo
patient
antibiot
treatment
prior
admiss
use
convent
method
blood
cultur
sputum
cultur
urinari
antigen
test
patient
test
posit
least
one
pathogen
ad
full
molecular
diagnost
packag
increas
diagnost
yield
frequent
detect
bacteri
pathogen
pneumonia
n
c
burnetii
n
patient
pneumonia
detect
pathogen
six
patient
c
burnetii
detect
pathogen
frequent
isol
viral
pathogen
hrv
n
n
major
patient
hrv
detect
combin
pathogen
patient
one
pathogen
detect
mix
infect
common
three
possibl
pathogen
list
tabl
major
patient
mix
infect
pneumonia
identifi
pneumonia
detect
blood
cultur
urinari
antigen
test
five
sputum
sampl
haemophilu
influenza
moraxella
catarrhali
staphylococcu
aureu
detect
sputum
cultur
escherichia
coli
gramneg
bacteria
isol
blood
cultur
sputum
cultur
pseudomona
aeruginosa
isol
blood
cultur
besid
qpcr
op
sputum
sampl
l
pneumophila
also
detect
urinari
antigen
test
three
patient
patient
also
posit
qpcr
op
andor
sputum
sampl
coxiella
burnetii
detect
four
serum
sampl
patient
also
qpcrposit
sputum
sampl
figur
posit
qpcr
op
andor
sputum
sampl
found
patient
patient
pathogen
detect
sputum
sampl
pathogen
detect
op
kipyv
wupyv
hcov
hcov
detect
op
wherea
c
psittaci
uniqu
found
sputum
tabl
sensit
detect
pathogen
ci
use
op
use
sputum
ci
bacteri
pathogen
often
detect
sputum
sampl
op
ci
versu
ci
p
except
hrv
rsv
sensit
detect
virus
use
op
higher
compar
use
sputum
sampl
ci
versu
ci
p
studi
demonstr
possibl
etiolog
diagnosi
found
high
proport
patient
cap
optim
sampl
broad
diagnost
packag
use
realiti
clinic
practic
major
patient
cap
undergo
limit
diagnost
test
demonstr
etiolog
agent
urin
antigen
test
avail
bacteri
sputum
cultur
good
qualiti
sputum
sampl
obtain
patient
cap
diagnost
yield
use
classic
method
cultur
may
limit
studi
bacteri
pathogen
cultur
sputum
sampl
slightli
higher
found
publish
report
isol
atyp
respiratori
bacteri
pathogen
exampl
pneumonia
c
pneumonia
difficult
pathogen
hardli
cultur
cell
cultur
timeconsum
studi
use
qpcr
sputum
sampl
increas
yield
significantli
pathogen
op
suitabl
detect
respiratori
virus
poorli
detect
convent
rapid
assess
virus
possibl
sensit
highli
specif
realtim
pcr
assay
util
swab
versu
wash
nose
versu
oropharyng
versu
nasopharyng
sampl
subject
consider
debat
lieberman
et
found
viral
pathogen
better
detect
nasopharyng
wash
offer
better
yield
nasal
op
procedur
poorli
toler
rare
use
hospit
patient
hand
de
la
tabla
et
report
combin
swab
superior
nasopharyng
aspir
detect
infla
combin
method
increas
detect
rate
studi
use
sputum
sampl
op
detect
viral
pathogen
found
op
equal
sensit
virus
except
hrv
rsv
falsey
et
found
studi
virus
detect
sputum
sampl
compar
swab
virus
detect
method
posit
swab
alon
posit
sputum
sampl
similar
studi
swab
sputum
test
yield
complementari
result
bacteri
pathogen
sputum
sampl
clearli
superior
op
similar
studi
elsewher
found
pneumonia
common
potenti
literatur
pneumonia
pcr
sputum
sampl
diagnost
tool
pneumococc
cap
mix
result
distinguish
colon
infect
difficult
even
quantifi
howev
patient
cap
tend
frequent
colon
pneumococci
asymptomat
patient
import
hypothesi
aspir
oropharyng
content
common
rout
develop
similarli
cultur
streptococci
sputum
sampl
conclus
evid
etiolog
role
therefor
valu
routin
detect
pneumonia
remain
matter
debat
similar
other
studi
show
molecular
detect
l
pneumophila
sputum
could
replac
urinari
antigen
practic
howev
requir
laboratori
setup
capabl
provid
diagnost
rapid
turnaround
time
situat
current
achiev
mani
set
studi
popul
rel
larg
number
c
burnetii
patient
cap
found
due
q
fever
outbreak
area
notifi
case
netherland
virus
result
compar
sampl
type
variabl
overal
base
data
conveni
sampl
procedur
op
would
prefer
sampl
type
except
hrv
rsv
find
agreement
publish
studi
focus
viral
pathogen
primari
caus
cap
remain
issu
consider
major
patient
cap
posit
hrv
second
respiratori
viru
bacteri
pathogen
hcov
never
found
singl
infect
addit
hrv
highli
preval
studi
also
found
hrv
common
asymptomat
person
find
suggest
howev
pathogen
includ
diagnost
packag
hrv
test
integr
sputum
panel
consist
bacteri
target
addit
hrv
rsv
may
relev
rsv
therapeut
option
avail
although
efficaci
antivir
patient
categori
remain
limit
studi
includ
lack
control
group
determin
preval
respiratori
pathogen
one
pathogen
isol
patient
nine
patient
three
pathogen
found
realtim
pcr
significantli
improv
sensit
detect
pathogen
often
possibl
determin
contribut
pathogen
detect
viral
bacteri
nucleic
acid
may
alway
repres
causat
studi
van
gageldonk
et
approxim
subject
respiratori
complaint
respiratori
viral
pathogen
detect
hand
lieberman
et
found
much
lower
preval
respiratori
virus
subject
respiratori
complaint
studi
subject
enrol
symptomat
would
increas
likelihood
isol
pathogen
caus
unfortun
observ
cohort
studi
abl
directli
determin
causat
quantit
rt
qpcr
data
would
use
help
address
question
whether
activ
infect
lower
respiratori
tract
instead
detect
residu
dnarna
prior
infect
asymptomat
carriag
final
includ
subset
patient
cap
reason
believ
patient
includ
would
substanti
differ
compar
studi
group
base
find
provid
target
bacteri
pcr
packag
sputum
test
separ
viral
packag
op
test
would
provid
almost
diagnost
yield
full
spectrum
test
use
studi
would
feasibl
result
pcr
avail
short
turnaround
time
look
diagnost
yield
sputum
packag
could
includ
hrv
rsv
test
would
lead
potenti
diagnosi
high
proport
cap
patient
critic
apprais
ad
valu
expand
diagnost
packag
need
given
cost
procedur
studi
need
evalu
impact
test
algorithm
patient
treatment
outcom
